TRIB3 gene expression, in contrast to TRIB3 protein expression [85], has been shown to correlate with poor prognosis in patients with breast cancer [86] and a poor prognosis in patients with non-small cell lung cancer (NSCLC) [87]. Here, TRIB3 is linked to breast carcinoma.